1. Home
  2. ANNX vs GLAS Comparison

ANNX vs GLAS Comparison

Compare ANNX & GLAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.39

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$10.73

Market Cap

940.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANNX
GLAS
Founded
2011
N/A
Country
United States
Employees
N/A
357
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
940.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ANNX
GLAS
Price
$5.39
$10.73
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
4.4M
287.8K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16,320.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$10.17
52 Week High
$7.18
$12.70

Technical Indicators

Market Signals
Indicator
ANNX
GLAS
Relative Strength Index (RSI) 47.18 38.95
Support Level $4.66 $10.17
Resistance Level $5.65 $11.96
Average True Range (ATR) 0.55 0.68
MACD -0.04 -0.09
Stochastic Oscillator 28.70 21.34

Price Performance

Historical Comparison
ANNX
GLAS

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

Share on Social Networks: